» Articles » PMID: 28123779

Multireader Assessment As an Alternative to Reference Assessment to Improve the Detection of Radiographic Progression in a Large Longitudinal Cohort of Rheumatoid Arthritis (ESPOIR)

Abstract

Introduction: Structural damage progression is a major outcome in rheumatoid arthritis (RA). Its evaluation and follow-up in trials should involve radiographic scoring by 1 or 2 readers (reference assessment), which is challenging in large longitudinal cohorts with multiple assessments.

Objectives: To compare the reproducibility of multireader and reference assessment to improve the feasibility of detecting radiographic progression in a large cohort of patients with early arthritis (ESPOIR).

Methods: We used 3 sessions to train 12 rheumatologists in radiographic scoring by the van der Heijde-modified Sharp score (SHS). Multireader scoring was based on 10 trained-reader assessments, each reader scoring a random sample of 1/5 of all available radiographs (for double scoring for each X-ray set) for patients included in the ESPOIR cohort with complete radiographic data at M0 and M60. Reference scoring was performed by 2 experienced readers. Scoring was performed blindly to clinical data, with radiographs in chronological order. We compared multireader and reference assessments by intraclass correlation coefficients (ICCs) for SHS and significant radiographic progression (SRP).

Results: The intrareader and inter-reader reproducibility for trained assessors increased during the training sessions (ICC 0.79 to 0.94 and 0.76 to 0.92), respectively. For the 524 patients included, agreement between multireader and reference assessment of SHS progression between M0 and M60 and SRP assessment were almost perfect, ICC (0.88 (95% CI 0.82 to 0.93)) and (0.99 (95% CI 0.99 to 0.99)), respectively.

Conclusions: Multireader assessment of radiographic structural damage progression is comparable to reference assessment and could be used to improve the feasibility of radiographic scoring in large longitudinal cohort with numerous X-ray evaluations.

Citing Articles

Ten-year radiographic and functional outcomes in rheumatoid arthritis patients in remission compared to patients in low disease activity.

Ruyssen-Witrand A, Guernec G, Dupont J, Lapuyade D, Liote F, Vittecoq O Arthritis Res Ther. 2023; 25(1):207.

PMID: 37864239 PMC: 10588022. DOI: 10.1186/s13075-023-03176-7.


Positive impact on 10-year outcome of the window of opportunity for conventional synthetic DMARDs in rheumatoid arthritis: results from the ESPOIR cohort.

Kedra J, Lafourcade A, Combe B, Dougados M, Hajage D, Fautrel B RMD Open. 2022; 8(1).

PMID: 35534053 PMC: 9086647. DOI: 10.1136/rmdopen-2021-002040.

References
1.
de Jong Z, Munneke M, Zwinderman A, Kroon H, Jansen A, Ronday K . Is a long-term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Results of a randomized controlled trial. Arthritis Rheum. 2003; 48(9):2415-24. DOI: 10.1002/art.11216. View

2.
van der Heijde D, van Leeuwen M, van Riel P, Koster A, van t Hof M, van Rijswijk M . Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis. Arthritis Rheum. 1992; 35(1):26-34. DOI: 10.1002/art.1780350105. View

3.
Colebatch A, Edwards C, Ostergaard M, van der Heijde D, Balint P, DAgostino M . EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis. 2013; 72(6):804-14. DOI: 10.1136/annrheumdis-2012-203158. View

4.
Taylor P, Steuer A, Gruber J, Cosgrove D, Blomley M, Marsters P . Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis. Arthritis Rheum. 2004; 50(4):1107-16. DOI: 10.1002/art.20123. View

5.
Boers M, Verhoeven A, Markusse H, van de Laar M, Westhovens R, van Denderen J . Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet. 1997; 350(9074):309-18. DOI: 10.1016/S0140-6736(97)01300-7. View